title: Oxaliplatin-induced immune thrombocytopenia.
authors.forename: Michel
authors.initials: M
authors.lastname: Pavic
authors.forename: Pierre
authors.initials: P
authors.lastname: Moncharmont
authors.forename: Pascal
authors.initials: P
authors.lastname: Sève
authors.forename: Dominique
authors.initials: D
authors.lastname: Rigal
authors.forename: Christiane
authors.initials: C
authors.lastname: Broussolle
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D015179:Colorectal Neoplasms / Q000188:drug therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D000077150:Oxaliplatin; D011696:Purpura, Thrombocytopenic / Q000139:chemically induced*
chemical_list: D009944:Organoplatinum Compounds; D000077150:Oxaliplatin